Stark^® Bovinos is indicated for the treatment of diseases in cattle (calves, breeding, growing and finishing cattle, and cows, including during pregnancy and lactation) caused by Escherichia coli, Fusobacterium necrophorum, Klebsiella pneumoniae, Pasteurella multocida, Staphylococcus aureus, and Streptococcus agalactiae, at a dose of 7.5 mg of enrofloxacin (equivalent to 0.075 mL of the product) per kilogram of body weight, administered intramuscularly as a single dose.